- Nebacumab
-
Nebacumab ? Monoclonal antibody Type Whole antibody Source Human Target endotoxin Clinical data AHFS/Drugs.com International Drug Names Pregnancy cat. ? Legal status ? Identifiers CAS number 138661-01-5 ATC code J06BC01 KEGG D05126 Chemical data Formula ? (what is this?) (verify) Nebacumab is a human monoclonal antibody developed for the treatment of sepsis.[1] It has been withdrawn in 1993 because it failed to reduce mortality in clinical trials.[2]
References
- ^ Derkx, B.; Wittes, J.; McCloskey, R. (1999). "Randomized, Placebo‐Controlled Trial of HA‐1A, a Human Monoclonal Antibody to Endotoxin, in Children with Meningococcal Septic Shock". Clinical Infectious Diseases 28 (4): 770–726. doi:10.1086/515184. PMID 10825037.
- ^ WHO: Consolidated List of Products
Monoclonal antibodies for infectious disease and toxins Fungal ("-fung-") Human ("-fungu-")Viral ("-vi(r)-") Human ("-viru-")Humanized ("-vizu-")Bacterial ("-ba(c)-") Human ("-bacu-")Nebacumab • Panobacumab • RaxibacumabMouse ("-baco-")Chimeric ("-baxi-")Humanized ("-bazu-")Toxin ("-tox(a)-") Humanized ("-toxazu-")Immune sera and immunoglobulins (J06) Polyclonal antibodies AntivenomMonoclonal antibodies Palivizumab · NebacumabThis antiinfective drug article is a stub. You can help Wikipedia by expanding it. This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it.